Literature DB >> 19541653

The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation.

Gregory A Peters1, Darcie D Seachrist, Ruth A Keri, Ganes C Sen.   

Abstract

PACT is a double-stranded RNA-binding protein that also binds and activates the latent protein kinase, PKR, which plays a major role in cellular antiviral defense in mammals. For evaluating PACT's contribution to the innate immune system, Pact(-/-) mice have been generated; these mice exhibit notable developmental abnormalities including microtia, with craniofacial, ear, and hearing defects. Here we report that, in addition, Pact(-/-) mice had smaller body size and fertility defects, both of which were caused by defective pituitary functions. Pact(-/-) mice exhibited anterior pituitary lobe (AL) hypoplasia, which developed postnatally, when the second phase of pituitary expansion occurs. Among the 5 cell types in AL, the numbers of corticotrophs, gonadotrophs, and somatotrophs were equally decreased in Pact(-/-) mice with a greater impact on lactotrophs and a lesser impact on thyrotrophs. PACT mRNA and protein were highly expressed in the pituitary of wild-type (Wt) mice during the postnatal wave of AL proliferation, the same period in which the hypoplasia developed in Pact(-/-) mice. During this time, the pituitaries of Pact(-/-) mice did not exhibit significantly increased apoptosis compared with Wt mice but showed a decrease in cell proliferation. The inhibition of cell proliferation observed in vivo could be recapitulated in vitro in GH3 somato/lactotroph and LbetaT2 gonadotroph cell lines; knockdown of PACT expression with siRNA diminished the rate of proliferation of these cells. Our study revealed a physiologically significant role for PACT in cell proliferation and an essential role of a dsRNA-binding protein in mammalian pituitary expansion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541653      PMCID: PMC2705576          DOI: 10.1073/pnas.0900735106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Immortalization of neuroendocrine cells by targeted oncogenesis.

Authors:  P L Mellon; J J Windle; R I Weiner
Journal:  Recent Prog Horm Res       Date:  1991

2.  PACT, a protein activator of the interferon-induced protein kinase, PKR.

Authors:  R C Patel; G C Sen
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

3.  Steroid and pulsatile gonadotropin-releasing hormone (GnRH) regulation of luteinizing hormone and GnRH receptor in a novel gonadotrope cell line.

Authors:  J L Turgeon; Y Kimura; D W Waring; P L Mellon
Journal:  Mol Endocrinol       Date:  1996-04

4.  Incorportaiton of thymidine and its analogue, bromodeoxyuridine, into embryos and maternal tissues of the mouse.

Authors:  D S Packard; R A Menzies; R G Skalko
Journal:  Differentiation       Date:  1973-12       Impact factor: 3.880

5.  Staufen, a gene required to localize maternal RNAs in the Drosophila egg.

Authors:  D St Johnston; D Beuchle; C Nüsslein-Volhard
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

6.  Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR.

Authors:  N Abraham; D F Stojdl; P I Duncan; N Méthot; T Ishii; M Dubé; B C Vanderhyden; H L Atkins; D A Gray; M W McBurney; A E Koromilas; E G Brown; N Sonenberg; J C Bell
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

7.  Ontogeny of hormone-secreting cells of the rat pituitary gland: an immunocytochemical study on dissociated cells.

Authors:  G Smets; B Velkeniers; P Herregodts; L Vanhaelst; W Gepts; E L Hooghe-Peters
Journal:  Histochem J       Date:  1989-06

8.  Growth hormone (GH)-releasing factor does not regulate GH release or GH mRNA levels in GH3 cells.

Authors:  F N Zeytin; G G Gick; P Brazeau; N Ling; M McLaughlin; C Bancroft
Journal:  Endocrinology       Date:  1984-06       Impact factor: 4.736

9.  RNA helicase A is essential for normal gastrulation.

Authors:  C G Lee; V da Costa Soares; C Newberger; K Manova; E Lacy; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  12 in total

1.  dsRNA binding protein PACT/RAX in gene silencing, development and diseases.

Authors:  Yue Yong; Jia Luo; Zun-Ji Ke
Journal:  Front Biol (Beijing)       Date:  2014-10

2.  PACT promotes the metastasis of basal-like breast cancer through Rac1 SUMOylation and activation.

Authors:  Luyao Wei; Wantao Wang; Junxia Yao; Zhengyu Cui; Zihang Xu; Hanqing Ding; Xiaojun Wu; Deheng Wang; Jia Luo; Zun-Ji Ke
Journal:  Oncogene       Date:  2022-08-16       Impact factor: 8.756

Review 3.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

4.  The protein activator of protein kinase R, PACT/RAX, negatively regulates protein kinase R during mouse anterior pituitary development.

Authors:  Benjamin K Dickerman; Christine L White; Patricia M Kessler; Anthony J Sadler; Bryan R G Williams; Ganes C Sen
Journal:  FEBS J       Date:  2015-10-26       Impact factor: 5.542

5.  RNA-induced silencing complex (RISC) Proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators.

Authors:  Andrew D Redfern; Shane M Colley; Dianne J Beveridge; Naoya Ikeda; Michael R Epis; Xia Li; Charles E Foulds; Lisa M Stuart; Andrew Barker; Victoria J Russell; Kerry Ramsay; Simon J Kobelke; Xiaotao Li; Esme C Hatchell; Christine Payne; Keith M Giles; Adriana Messineo; Anne Gatignol; Rainer B Lanz; Bert W O'Malley; Peter J Leedman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-02       Impact factor: 11.205

6.  Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein.

Authors:  Chun Kew; Pak-Yin Lui; Chi-Ping Chan; Xiang Liu; Shannon Wing Ngor Au; Ian Mohr; Dong-Yan Jin; Kin-Hang Kok
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

7.  Missense mutation in the second RNA binding domain reveals a role for Prkra (PACT/RAX) during skull development.

Authors:  Benjamin K Dickerman; Christine L White; Claire Chevalier; Valérie Nalesso; Cyril Charles; Sophie Fouchécourt; Florian Guillou; Laurent Viriot; Ganes C Sen; Yann Hérault
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

8.  The Human dsRNA binding protein PACT is unable to functionally substitute for the Drosophila dsRNA binding protein R2D2.

Authors:  Benjamin K Dickerman; Jocelyn A McDonald; Ganes C Sen
Journal:  F1000Res       Date:  2013-10-18

9.  Tombusvirus P19 RNA silencing suppressor (RSS) activity in mammalian cells correlates with charged amino acids that contribute to direct RNA-binding.

Authors:  Xiang Liu; Laurent Houzet; Kuan-Teh Jeang
Journal:  Cell Biosci       Date:  2012-12-06       Impact factor: 7.133

10.  miR-29a/b1 Regulates the Luteinizing Hormone Secretion and Affects Mouse Ovulation.

Authors:  Yang Guo; Youbing Wu; Jiahao Shi; Hua Zhuang; Lei Ci; Qin Huang; Zhipeng Wan; Hua Yang; Mengjie Zhang; Yutong Tan; Ruilin Sun; Leon Xu; Zhugang Wang; Ruling Shen; Jian Fei
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-31       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.